Introduction
Castleman's disease or angiofollicular lymph node hyperplasia is a rare disorder characterised by benign proliferation of lymphoid tissue. It was first described by Benjamin Castleman in 1950. It may be localised / unicentric or disseminated /systemic/ multicentric. Histologically, it is classified as hyaline vascular type, plasma cell type and a mixed type. [1] The unicentric type can be treated and cured by surgery. To date, approximately 1000 cases of Castleman's disease have been reported in the literature. [2, 4] We report
Case Report
A 16 year old male presented with complain of painless lump in the left lumbar region of three months. The patient did not have any constitutional symptoms. On physical examination a mobile lump of size 9.0 cm x 8.0 cm noted in the left lumbar region. The lump was mobile, had nodular surface and was firm in consistency. There was no family history of similar illness or cancer. Routine laboratory investigation and chest X-rays were normal. Abdominal sonography revealed a hetero echoic mass of size 9.0 cm x 8.0 cm with calcification in left lumbar region. CECT revealed hypodense enhancing mass measuring 9.0 cm x 8.0 cm x 6.5 cm with rim like calcification [ Fig  1] . At laparotomy, the mass was found attached to the root of mesentery and complete resection of mass was undertaken. Macroscopically, the mass measured 9.0 cm x 8.0 cm x 60 cm. The tissue was grey white, capsulated and lobulated. (Fig.2 ) Cut section shows grey white hemorrhagic surface. [3] Majority of the patient are asymptomatic. Pre-operative diagnosis of hyaline vascular Castleman disease is difficult. The usual appearance of the disease on CT or MRI is that of a mass with or without calcification with enhancement on post contrast study.
The histological subtype of Castleman's disease is: (Table 1) hyaline vascular variant (unicentric in 72%); plasma cell variant (unicentric in 18% and multicentric in 10%); mixed variant and a plasmablastic variant of Castleman disease. [4] Only 10% to 17% cases involve the abdomen, of which the majority of cases are retroperitoneal. The plasmablastic variant of the disease is commonly associated with HHV-8 and tends to have a poor prognosis. The multicentric and especially, HHV-8 positive types are risk factors for the development of Hodgkin lymphoma, nonHodgkin lymphoma and Kaposi sarcoma. It has been hypothesized that HHV-8 induces the changes of Castleman disease through the production of interleukin-6. Multicentric Castleman disease may be seen in association with the POEMS syndrome. [5] Most patient with multicentric Castleman disease die from progression of their disease, disseminated infection or related malignancies. Laboratory studies with blood count, Creactive protein, interleukin-6, HIV, HHV-8 testing should be done. CT and MRI is non diagnostic. Kim et al described two types of radiological manifestation in abdominal Castleman disease: a localised type and a disseminated type. [6] The hyaline vascular variant shows high enhancement on CT whereas plasma cell variant shows low enhancement. In our case the mass showed a high degree of enhancement on post contrast CT scan. In a recently published study, 'rim like' enhancement, a predominantly left sided location in the retroperitoneum, and the presence of peritoneal thickening were described as relatively characteristic findings of the disease. Non-specific features like necrosis, fibrosis and calcifications can be observed. In our case, mass was located on left side with a rim like calcification. A variety of treatments have been used for multicentric Castleman disease including surgery, radiation, steroids, antiviral agents, specific antibodies, inhibitors of cytokines activity and chemotherapy. Surgery generally does not have a role in the treatment of multicentric Castleman disease. The unicentric type if resected completely is not associated with increased mortality and is known to have excellent prognosis. Therefore, radical surgical resection is considered to be gold standard therapy in these cases. [5] Patient with unicentric disease should receive radiological follow up every 6 to 12 months.
Conclusion
Castleman's disease is a rare disorder that remains a diagnostic challenge. Radical surgical resection is considered to be gold standard for treating the unicentric variant. This type is not associated with increased mortality as long as resection is radical and complete.
